Harnessing pharmacogenomics to tackle resistance to the "nucleoside reverse trancripatse inhibitor" backbone of highly active antiretroviral therapy in resource limited settings (Q37410853)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Harnessing pharmacogenomics to tackle resistance to the "nucleoside reverse trancripatse inhibitor" backbone of highly active antiretroviral therapy in resource limited settings
scientific article

    Statements

    Harnessing pharmacogenomics to tackle resistance to the "nucleoside reverse trancripatse inhibitor" backbone of highly active antiretroviral therapy in resource limited settings (English)
    Misaki Wayengera
    Henry Kajumbula
    Wilson Byarugaba
    5 November 2008
    78-81

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit